PHAT — Phathom Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $567.12m
- $934.14m
- $175.11m
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates
Brief: Phathom Pharmaceuticals Q1 Net Income USD -30.369 Million
U.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
U.S. STOCKS ON THE MOVE-Alphabet, Phathom, Argan
Barclays raises Phathom Pharmaceuticals to 'overweight'; shares rise
Phathom Pharmaceuticals Q4 revenue slightly beats expectations
U.S. STOCKS ON THE MOVE-Constellation Brands, General Motors, Ford
Phathom Pharmaceuticals tumbles on $130 mln equity raise
Brief: Phathom Pharmaceuticals Announces Pricing Of Public Offering Of 6.87 Mln Shares at $16.00 Each
Brief: Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Phathom Pharmaceuticals drops after announcing planned equity raise
Brief: Phathom Pharmaceuticals Files For Mixed Shelf Offering Size Not Disclosed- SEC Filing
Phathom Q3 revenue up 25%, beats estimates
U.S. RESEARCH ROUNDUP -ANI Pharmaceuticals, Berkshire Hathaway, Chevron
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary